In cooperation with Misr El Kheir Foundation Novo Nordisk launches initiative ensuring Iftar for 10,000 people in 5 provinces

Cairo 26 July, 2014Novo Nordisk, one of the world's pharmaceutical leaders, together with Misr El Kheir Foundation, launched an initiative aiming to ensure Iftar for 10,000 people over the last 10 days of the holy month of Ramadan, in line with the company's strategy to support communities in which it operates.

  
Novo Nordisk team volunteers time & effort for charitable initiatives & community development
Cairo 26 July, 2014

Novo Nordisk, one of the world's pharmaceutical leaders, together with Misr El Kheir Foundation, launched an initiative aiming to ensure Iftar for 10,000 people over the last 10 days of the holy month of Ramadan, in line with the company's strategy to support communities in which it operates.

Through its initiative, Novo Nordisk pays special attention to covering a large number of underprivileged areas in 5 different provinces nationwide. 

"This initiative has emerged out of Novo Nordisk belief in its corporate social responsibility that not only provides vital treatments, but is always keen on taking part in charitable initiatives, playing a vital role in community development through partnership with organizations such as Misr El Kheir, utilizing their extended experience and well known contributions to develop the Egyptian society," Said Dr. Mohamed El Dababy the General manager, of NovoNordisk Egypt.

"Novo Nordisk backs many charitable initiatives nationwide in light of its corporate social responsibility. The company's employees always dedicate their time and effort for similar charitable initiatives, in addition to their financial contributions. Novo Nordisk believes in its essential role in the community in which it operates, and always eager to develop it," added dr. El Dababy

"This initiative is launched to help many low-income people who suffer tough economic circumstances in line with Misr El Kheir projects that aim to develop Egyptian citizens. According to its database, the Foundation determined the neediest families in different provinces. Misr El Kheir undertook its mission, including the contracts signed for high quality meals to be distributed on Ramadan fasters," said Magdy Selim, Head of Studies and Implementation at Misr El Kheir Foundation. The initiative covers "Shakshouk" village in "Ebshway" area in Fayoum province, "Zawyat Abu Mosallam" in "Abu El Nomros" area in Giza province, "Ferhas" village in "Hosh Essa" in Beheera province, "El Hawees" area in "Al Arbaien" district in Suez province, and in Menia province as well.

-End-

About Novo Nordisk:
Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy.

 Novo Nordisk has offices in 68 countries and markets its products in approximately 180 countries. It has the largest Insulin factory worldwide, as it owns Steno Diabetes Center, world's leading 'none profit' institution in diabetes care and prevention.

Novo Nordisk employs around 40,000 employees; it launched world's first human Insulin in 1982 and first Insulin pen in 1985.

About Misr El Kheir
Misr El Kheir is a developmental non-profit organization, registered according to the decree 555/2007, to receive alms and Zakaah and distribute them according to the Islamic teachings. It also invests alms money to generate a return to be spent on several projects. The foundation aims at taking part in human development, boosting education, research, healthcare and social solidarity systems. Our dream is to eliminate unemployment, illiteracy, poverty and disease. Our main target is to be a leading foundation, representing a global model to be followed, to create a self-sufficient community in terms of growth. ​

© Press Release 2014

More From Press Releases